Literature DB >> 28441491

A Naturally Occurring Isoform-Specific Probe for Highly Selective and Sensitive Detection of Human Cytochrome P450 3A5.

Jing-Jing Wu1, Yun-Feng Cao1,2, Liang Feng1, Yu-Qi He3, James Y Hong4, Tong-Yi Dou1, Ping Wang1, Da-Cheng Hao5, Guang-Bo Ge1, Ling Yang6.   

Abstract

Cytochrome P450 (CYP) 3A5 characterized with polymorphic and extensive expression in multiple tissues is the most important P450 enzyme among the minor CYP3A isoforms. However, a selective and sensitive probe for CYP3A5 remains unavailable. In this study, we identified and characterized a naturally occurring lignan 12 (schisantherin E) as an isoform-specific probe for selective detection of CYP3A5 activity in complex biological samples. With thorough characterization including LC-MS and NMR, we found that 12 can be metabolized by CYP3A5 to generate a major metabolite 2-O-demethylated 12. Meanwhile, both reaction phenotyping and chemical inhibition experiments further revealed that CYP3A5 selectively catalyzed the 2-O-demethylation of 12. Specifically, the interactions between the Phe210 residue of CYP3A5 and methyl benzoate of 12 might play key roles in 12-O-demethylation, which was revealed by docking simulation and site-directed mutagenesis studies. These findings are beneficial for exploring the role of CYP3A5 in drug metabolism and pathologic process.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28441491     DOI: 10.1021/acs.jmedchem.7b00001

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Active-site differences between substrate-free and ritonavir-bound cytochrome P450 (CYP) 3A5 reveal plasticity differences between CYP3A5 and CYP3A4.

Authors:  Mei-Hui Hsu; Eric F Johnson
Journal:  J Biol Chem       Date:  2019-03-29       Impact factor: 5.157

2.  Crystal Structures of Drug-Metabolizing CYPs.

Authors:  D Fernando Estrada; Amit Kumar; Christopher S Campomizzi; Natalie Jay
Journal:  Methods Mol Biol       Date:  2021

3.  The X-Ray Crystal Structure of the Human Mono-Oxygenase Cytochrome P450 3A5-Ritonavir Complex Reveals Active Site Differences between P450s 3A4 and 3A5.

Authors:  Mei-Hui Hsu; Uzen Savas; Eric F Johnson
Journal:  Mol Pharmacol       Date:  2017-11-01       Impact factor: 4.436

4.  Unraveling the Structural Basis of Selective Inhibition of Human Cytochrome P450 3A5.

Authors:  Jingheng Wang; Cameron D Buchman; Jayaraman Seetharaman; Darcie J Miller; Andrew D Huber; Jing Wu; Sergio C Chai; Efren Garcia-Maldonado; William C Wright; Jude Chenge; Taosheng Chen
Journal:  J Am Chem Soc       Date:  2021-10-14       Impact factor: 15.419

Review 5.  PharmVar GeneFocus: CYP3A5.

Authors:  Cristina Rodriguez-Antona; Jessica L Savieo; Volker M Lauschke; Katrin Sangkuhl; Britt I Drögemöller; Danxin Wang; Ron H N van Schaik; Andrei A Gilep; Arul P Peter; Erin C Boone; Bronwyn E Ramey; Teri E Klein; Michelle Whirl-Carrillo; Victoria M Pratt; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2022-02-24       Impact factor: 6.903

6.  Cytochrome P450 2E1 predicts liver functional recovery from donation after circulatory death using air-ventilated normothermic machine perfusion.

Authors:  Ji-Hua Shi; Dong-Jing Yang; Qiang Jin; Nuo Cheng; Yuan-Bin Shi; Yang Bai; Dong-Sheng Yu; Wen-Zhi Guo; Guang-Bo Ge; Shui-Jun Zhang
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

7.  Identification of Potential Cytochrome P450 3A5 Inhibitors: An Extensive Virtual Screening through Molecular Docking, Negative Image-Based Screening, Machine Learning and Molecular Dynamics Simulation Studies.

Authors:  Md Ataul Islam; Dawood Babu Dudekula; V P Subramanyam Rallabandi; Sridhar Srinivasan; Sathishkumar Natarajan; Hoyong Chung; Junhyung Park
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

Review 8.  Pharmaceutical resource discovery from traditional medicinal plants: Pharmacophylogeny and pharmacophylogenomics.

Authors:  Da-Cheng Hao; Pei-Gen Xiao
Journal:  Chin Herb Med       Date:  2020-03-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.